Menu
GeneBe

4-2818299-G-A

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The ENST00000511747.6(SH3BP2):c.76G>A(p.Gly26Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000358 in 1,069,268 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

SH3BP2
ENST00000511747.6 missense

Scores

3
1
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.00600
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.061558843).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00171 (252/147416) while in subpopulation AFR AF= 0.00571 (234/40978). AF 95% confidence interval is 0.00511. There are 1 homozygotes in gnomad4. There are 114 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd at 247 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SH3BP2NM_001122681.2 linkuse as main transcriptc.-4-2315G>A intron_variant ENST00000503393.8
SH3BP2NM_001145856.2 linkuse as main transcriptc.76G>A p.Gly26Arg missense_variant 1/13
SH3BP2NM_001145855.2 linkuse as main transcriptc.81-2315G>A intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SH3BP2ENST00000503393.8 linkuse as main transcriptc.-4-2315G>A intron_variant 1 NM_001122681.2 P2P78314-1

Frequencies

GnomAD3 genomes
AF:
0.00168
AC:
247
AN:
147314
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00560
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000876
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000151
Gnomad OTH
AF:
0.00197
GnomAD4 exome
AF:
0.000142
AC:
131
AN:
921852
Hom.:
0
Cov.:
29
AF XY:
0.000151
AC XY:
65
AN XY:
431342
show subpopulations
Gnomad4 AFR exome
AF:
0.00639
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000555
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000487
GnomAD4 genome
AF:
0.00171
AC:
252
AN:
147416
Hom.:
1
Cov.:
32
AF XY:
0.00159
AC XY:
114
AN XY:
71794
show subpopulations
Gnomad4 AFR
AF:
0.00571
Gnomad4 AMR
AF:
0.000874
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000151
Gnomad4 OTH
AF:
0.00195
Alfa
AF:
0.00169
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 10, 2021The c.76G>A (p.G26R) alteration is located in exon 1 (coding exon 1) of the SH3BP2 gene. This alteration results from a G to A substitution at nucleotide position 76, causing the glycine (G) at amino acid position 26 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.40
Cadd
Benign
14
Dann
Uncertain
0.98
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.0089
N
LIST_S2
Benign
0.32
T
M_CAP
Pathogenic
0.66
D
MetaRNN
Benign
0.062
T
MetaSVM
Benign
-0.82
T
MutationTaster
Benign
1.0
N;N;N;N;N;N
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.12
N
REVEL
Benign
0.21
Sift
Pathogenic
0.0
D
Vest4
0.12
MutPred
0.18
Gain of methylation at G26 (P = 0.0095);
MVP
0.74
MPC
0.19
ClinPred
0.48
T
GERP RS
1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.6

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs866128602; hg19: chr4-2820026; API